Skip to main content

Table 3 Characteristics of trials included in this review

From: Use of routine healthcare data in randomised implementation trials: a methodological mixed-methods systematic review

Type of trials

 Implementation trials

55

68.8%

 Type II hybrid trials

15

18.8%

 Type III hybrid trials

10

12.5%

Implementation strategy

 Single strategy

24

30.0%

 Multicomponent strategy

56

70.0%

Comparator

 Usual care/no intervention

60

75.0%

 Active comparatora

20

25.0%

Evidence-based intervention

 Clinical guidelines

18

22.5%

 Vaccinations

9

11.3%

 Disease screening

12

15.0%

 Disease management programme

5

6.3%

 Otherb

36

45.0%

Implementation outcome

 Adoption

52

65.0%

 Fidelity

12

15.0%

 Acceptability/feasibility

3

3.8%

 Combinationsc

13

16.3%

  1. aActive implementation components such as letter reminders, educational materials, workshops, questionnaire, training
  2. bEvidence-based treatment/service (e.g. breastfeeding, antiplatelet medications, tobacco use prevention and cessation counselling, evidence-based weight management services, advance care planning), model of care, and combinations of screening, vaccinations, and guidelines
  3. cMixed combinations of adoption, implementation cost, feasibility, fidelity, penetration, sustainability, acceptability
Back to article page

Implementation Science

ISSN: 1748-5908